Literature DB >> 965094

Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice.

C B Walker, T D Wilkins.   

Abstract

The development of a pure Bacteroides fragilis infection in mice is described. The infection produces large subcutaneous abscesses at the site of injection which can be observed grossly within 7 days after injection. The infection was initiated by infection of pure cultures grown in semisolid agar medium. Similar infections were also produced with pure cultures of B. distasonis, B. ovatus, B. thetaiotaomicron, and B. vulgatus. However, a distinct deoxyribonucleic acid homology group, formerly classified as B. thetaiotaomicron, did not produce abscesses in any of the mice tested.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 965094      PMCID: PMC420946          DOI: 10.1128/iai.14.3.721-725.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Micromethod for identification of anaerobic bacteria: design and operation of apparatus.

Authors:  T D Wilkins; C B Walker; W E Moore
Journal:  Appl Microbiol       Date:  1975-11

2.  Development of a micromethod for identification of anaerobic bacteria.

Authors:  T D Wilkins; C B Walker
Journal:  Appl Microbiol       Date:  1975-11

3.  Use of anaerobic glove boxes for the cultivation of strictly anaerobic bacteria.

Authors:  A Aranki; R Freter
Journal:  Am J Clin Nutr       Date:  1972-12       Impact factor: 7.045

4.  Liver abscess production by non-spore-forming anaerobic bacteria in a mouse model.

Authors:  G B Hill; S Osterhout; P C Pratt
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

5.  In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.

Authors:  A S Hackman; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

  5 in total
  21 in total

1.  Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.

Authors:  R J Boon; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  Chemotherapy of an experimental Bacteroides fragilis infection in mice.

Authors:  C B Walker; D Nitzan; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

3.  Therapy of anaerobic infections.

Authors:  T D Wilkins; S E West
Journal:  Infection       Date:  1983       Impact factor: 3.553

Review 4.  Aspects of anaerobic infections in animals.

Authors:  H S Goldberg
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Antibody response following subcutaneous and intraperitoneal injection of Bacteroides fragilis in rabbits.

Authors:  M E Landay
Journal:  Eur J Clin Microbiol       Date:  1982-08       Impact factor: 3.267

6.  Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.

Authors:  P L Goldman; D T Durack; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

7.  Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.

Authors:  H Hof; A Christen; J Hacker
Journal:  Infection       Date:  1986 Jul-Aug       Impact factor: 3.553

8.  Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.

Authors:  T M Ellis; J T Barrett
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Encapsulation of Bacteroides species.

Authors:  J L Babb; C S Cummins
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Polymorphonuclear neutrophil chemotaxis induced and inhibited by Bacteroides spp.

Authors:  S A Adamu; J F Sperry
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.